Brief: Prime Medicine, Inc. Q2 Operating Expenses USD 54.492 Million
07/08/2025 13:11
Aug 7 (Reuters) - Prime Medicine Inc PRME.O: PRIME MEDICINE, INC. Q2 OPERATING EXPENSES USD 54.492 MILLION PRIME MEDICINE, INC. Q2 PRETAX PROFIT USD -52.591 MILLION PRIME MEDICINE, INC. Q2 NET INCOME USD -52.591 MILLION PRIME MEDICINE, INC. Q2 INCOME FROM OPERATIONS USD -53.377 MILLION PRIME MEDICINE, INC. Q2 EPS USD -0.41 Source text: ID:nGNX1Dv1Fk Further company coverage: PRME.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prime Medicine
See all newsBrief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm647 In Alpha-1 Antitrypsin Deficiency
Prime Medicine, Inc. reports results for the quarter ended June 30 - Earnings Summary
Prime Medicine Q2 net loss narrows on lower expenses
Brief: Prime Medicine, Inc. Q2 EPS USD -0.24
Brief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm577a In H1069q-Mutated Wilson Disease